ARCHIVES

Phase III Xilonix Study Halted Following Unscheduled Analysis

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Greenwald Reorganizing DCPC, Elevates Surveillance to Program, Moves Branches

February 3, 1989

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

July 30, 1999

Gigliotti Appointed Chief of Education Branch In DRCCA

January 21, 1983

FDA Approves Imaging Agent For Recurrent Prostate Cancer

September 28, 2012

Harold Varmus Nominated For NIH Director; Selection Wins Support of Biomedical Community

August 13, 1993

NCI To Support 39 Summer Students With Gift Money

February 8, 1985